Wu Hu-ping, Xie Su-zhen, Dong Nuo, Yan Lei, Liu Zhao-sheng
Ocular Surface and Corneal Disease Department, Affiliated Xiamen Eye Center of Xiamen University, Xiamen 361001, China.
Zhonghua Yan Ke Za Zhi. 2010 Mar;46(3):238-42.
To investigate the feasibility and clinical effect of non-Descemet stripping endothelial keratoplasty for bullous keratopathy.
In the prospective consecutive case series, 6 patients (6 eyes) with bullous keratopathy at Affiliated Xiamen Eye Center of Xiamen University from September 2007 to January 2009 underwent non-Descemet stripping endothelial keratoplasty. During the surgical procedures, the recipient's Descemet membrane and endothelial layer were left untreated. The donor tissue disc consisting of posterior stroma and healthy endothelium from a donor cornea was implanted into the anterior chamber from a limbal tunnel incision, then unfolded and pressed against the recipient cornea with sterile air filled in anterior chamber. All patients were followed up for 6 - 20 months, pre- and postoperative best corrected visual acuity (BCVA) were compared, the adherence of the donor disc to the recipient endothelium and postoperative donor disc dislocation were monitored during the follow-up period. Graft clearance and endothelial cell density (ECD) were observed, too.
Five donor disc were well adhered to the recipient endothelium and no graft dislocation occurred during the follow-up period. One case showed a narrow gap between the host endothelium and donor disc 1 day postoperatively. This patient was told to stay in prone position and the donor disc readhered well. All the grafts remained transparent until the latest follow-up. Five patients had improved BCVA while 1 patient had the same BCVA. The reason for poor VA was optic atrophy due to trauma. Postoperative mean EDC was (1648 + or - 384) cells/mm(2).
Non-Descemet stripping endothelial keratoplasty for bullous keratopathy is feasible, technically easy, safe and effective. It can be one of the surgical treatment option for bullous keratopathy.
探讨非穿透性后弹力层剥除内皮角膜移植术治疗大泡性角膜病变的可行性及临床效果。
在这项前瞻性连续病例系列研究中,2007年9月至2009年1月期间,厦门大学附属厦门眼科中心的6例(6眼)大泡性角膜病变患者接受了非穿透性后弹力层剥除内皮角膜移植术。手术过程中,受体的后弹力层和内皮细胞层未作处理。将取自供体角膜的包含后基质层和健康内皮细胞的供体组织片经角膜缘隧道切口植入前房,然后展开并用充满前房的无菌空气将其压贴于受体角膜上。所有患者均随访6至20个月,比较术前和术后的最佳矫正视力(BCVA),随访期间监测供体组织片与受体内皮细胞的贴合情况以及术后供体组织片脱位情况。同时观察植片透明情况和内皮细胞密度(ECD)。
5例供体组织片与受体内皮细胞贴合良好,随访期间未发生植片脱位。1例患者术后1天在宿主内皮细胞与供体组织片之间出现狭窄间隙。告知该患者保持俯卧位,之后供体组织片重新贴合良好。直至最后一次随访时,所有植片均保持透明。5例患者的BCVA有所提高,1例患者的BCVA无变化。视力不佳的原因是外伤导致的视神经萎缩。术后平均内皮细胞密度为(1648±384)个/mm²。
非穿透性后弹力层剥除内皮角膜移植术治疗大泡性角膜病变是可行的,技术操作简便,安全有效。它可成为大泡性角膜病变的手术治疗选择之一。